JD

Juri Deka Barman

Active Director Director DIN 09156786
DIN 09156786 First appointment Apr 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Juri Deka Barman

Data last updated:

Juri Deka Barman is a Director at New Barman Healthcare Private Limited (since 2021) and Director at Barman Infracon Private Limited (since 2021). The companies operate in Chemicals and Construction.

DIN 09156786
Primary Designation Director
Industry Chemicals
First Appointment 23 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 May 20212021Active
Barman Infracon Private Limited U45309AS2021PTC021289
Director23 Apr 20212021Active

Board colleagues of Juri Deka Barman

Directorship timeline

Open interactive timeline →
New Barman Healthcare Private Limited
Barman Infracon Private Limited
Premium access

Shareholding and investment profile for Juri Deka Barman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Juri Deka Barman

Juri Deka Barman currently holds 2 directorships: New Barman Healthcare Private Limited (Director, since 15 May 2021); Barman Infracon Private Limited (Director, since 23 Apr 2021).

Juri Deka Barman was first appointed on 23 Apr 2021 as Director at Barman Infracon Private Limited.

The current boards of Juri Deka Barman's companies include Jatindra Barman (New Barman Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available